Luteal changes after treatment with sub-luteolytic doses of prostaglandin (cloprostenol sodium) in cattle

Anim Reprod Sci. 2015 Feb:153:8-12. doi: 10.1016/j.anireprosci.2014.12.005. Epub 2014 Dec 26.

Abstract

This study characterizes the physiological and morphological changes related to partial luteolysis in bovine corpus luteum (CL) after challenges with sub-doses of cloprostenol sodium on Day 6 (D6) of the estrous cycle. Cows (n = 12/treatment) were treated as follows: Control (2 mL, saline, i.m.); 2XPGF (two treatments i.m. 500 μg of cloprostenol sodium 2 h apart) and 1/6PGF (83.3 μg of cloprostenol sodium, i.m., once). Plasma progesterone (P4) concentration, CL volume and blood flow were measured immediately before the treatments, then every 8 h (h) for 48 h. In the Control, P4 concentrations were higher at 48 h than at 0 h. P4 decreased 8h after 2XPGF treatment (P < 0.05), and remained low until the end of the trial. P4 decreased in 1/6PGF between 8 and 16 h (P < 0.05), then began to rebound at 24 h. Luteal volume was higher in Controls at 48 h than at 0 h. Under 1/6PGF, luteal volume decreased at 24 h (P < 0.05) and began to rebound at 32 h. Luteal volume and blood flow were reduced starting at 24 and 32 h, respectively, after 2XPGF treatment (P < 0.05). In this study, we were able to describe the partial luteolysis phenomenon, induced by a treatment of a D6CL with cloprostenol sub-dose.

Keywords: Corpus luteum; Cow; Partial luteolysis.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cattle*
  • Cloprostenol / pharmacology*
  • Corpus Luteum / anatomy & histology*
  • Corpus Luteum / blood supply
  • Corpus Luteum / diagnostic imaging
  • Corpus Luteum / drug effects*
  • Dose-Response Relationship, Drug
  • Female
  • Luteal Phase / blood
  • Luteal Phase / drug effects
  • Luteolysis / drug effects
  • Luteolytic Agents / pharmacology*
  • Organ Size / drug effects
  • Progesterone / blood
  • Regional Blood Flow / drug effects
  • Ultrasonography

Substances

  • Luteolytic Agents
  • Cloprostenol
  • Progesterone